Not even two weeks into an extraordinary response to the novel coronavirus outbreak, the upper echelons of capital are wondering whether saving millions of lives is really worth the damage being done to their investment portfolios. According to reports, the debate among the ruling class is over whether or not to walk back some of the measures taken to slow the spread of the virus—efforts already considered tardy and inadequate by public health experts—in order to minimize business losses. Continue reading
Sections
-
Recent Posts